Research and Markets - Global In-vitro Diagnostics Instruments Market 2016-2020: Market Growth at CAGR of 9.73% - Key Vendors are Abbott Labs, Danaher, Roche Diagnostics, Siemens Healthcare & Thermo Fisher Scientific
DUBLIN, Dec 14, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Global In-vitro Diagnostics Instruments Market 2016-2020" report to their offering.
The global in-vitro diagnostics instruments market to grow at a CAGR of 9.73% during the period 2016-2020.
Global In-vitro Diagnostics Instruments Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
The POL test segments are related to actionable infectious disease markers, cardiovascular diseases, and diabetes care. Most common infectious disease testing has enabled the usage of molecular diagnostic instruments in the POL practice. Many instruments that are usually used for testing in the central labs, now support the testing in POL. While CLIA testing for such molecular assays would increase its market growth, certain regulatory aspects over CLIA-waived test would likely delay its market growth.
According to the report, POCT testing for cardiovascular biomarkers is a strategic IVD focus area even for non-traditional healthcare companies. In 2011, Samsung Electronics acquired Nexus Dx, a developer of rapid POC tests for diagnosing cardiovascular disease. Loss of employer sponsored health plans due to unemployment drove many Americans to seek other ways of receiving routine healthcare. Retail clinics, pharmacies, and home care settings have gained popularity because of added conveniences.
Further, the report states that IVD industry consolidation intensified since 2012. Crucial deals in 2012 include Hologic's acquisition of Gen-Probe and Life Technologies' acquisition of Navigenics, a genetic testing laboratory. The other notable consolidation includes larger company like Agilent) with considerable resources and has increased the ability for the acquiring company to compete and control market dynamics in its favor. This is threatening the market entry of small companies.
Key vendors
- Abbott Laboratories
- Danaher
- Roche Diagnostics
- Siemens Healthcare
- Thermo Fisher Scientific
Other prominent vendors
- A&T
- A. Menarini Diagnostics
- Abaxis
- Abcam
- Accriva Diagnostics
- Acon Laboratories
- Affymetrix
- Ahram Biosystem
- ARKRAY
- AsuraGen
- Biocartis
- Bio-Rad Laboratories
- CellaVision
- Cepheid
- Chembio Diagnostic Systems
- Chembio Diagnostic Systems
- Clarity Diagnostics
- Corgenix
- DiagCor
- Drucker Diagnostics
- EKF Molecular Diagnostics
- Erba Diagnostics
- GREEN CROSS MEDIS
- Helena Laboratories
- Hologic
- HORIBA
- Instrumentation Laboratory
- i-Sens
- Landwind Medical
- Mindray
- Nihon Kohden
- Nipro Diagnostics
- Randox Laboratories
- Sekisui Medical
- Sienco
- Sinduri Biotec
- Trivitron Healthcare
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Market research methodology
Part 04: Introduction
Part 05: Market landscape
Part 06: Market segmentation by product
Part 07: Market segmentation by end-user
Part 08: Geographical segmentation
Part 09: Focus on emerging markets
Part 10: Market drivers
Part 11: Impact of drivers
Part 12: Market challenges
Part 13: Impact of drivers and challenges
Part 14: Market trends
Part 15: Vendor landscape
Part 16: Key vendor analysis
Part 17: Appendix
For more information about this report visit http://www.researchandmarkets.com/research/6h7bfv/global_invitro
Media Contact:
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Share this article